Dr. Ankit Mangla, MD
Claim this profileCase Western Reserve University
Studies Skin Cancer
Studies Melanoma
11 reported clinical trials
18 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
BRAF positive
2Melanoma
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Ankit Mangla, MD is currently running
CDK4/6 Inhibitor
for Liposarcoma
This trial tests SPH4336, a chemotherapy pill, in patients with CDK4-positive liposarcomas. The drug works by blocking an enzyme that cancer cells need to grow, aiming to stop tumor growth.
Recruiting1 award Phase 2
Cemiplimab + Palbociclib
for Liposarcoma
This phase II trial compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with dedifferentiated liposarcoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Palbociclib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Cemiplimab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. The combination of these two drugs may be more effective in shrinking or stabilizing advanced dedifferentiated liposarcoma compared to palbociclib alone.
Recruiting1 award Phase 2
More about Ankit Mangla, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Ankit Mangla, MD has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Mirdametinib
- BGB-3245
- CAB-AXL-ADC
Breakdown of trials Ankit Mangla, MD has run
Skin Cancer
Melanoma
Sarcoma
Cutaneous Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ankit Mangla, MD specialize in?
Ankit Mangla, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ankit Mangla, MD currently recruiting for clinical trials?
Yes, Ankit Mangla, MD is currently recruiting for 9 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Ankit Mangla, MD has studied deeply?
Yes, Ankit Mangla, MD has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Ankit Mangla, MD?
Apply for one of the trials that Ankit Mangla, MD is conducting.
What is the office address of Ankit Mangla, MD?
The office of Ankit Mangla, MD is located at: Case Western Reserve University, Cleveland, Ohio 44106 United States. This is the address for their practice at the Case Western Reserve University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.